IRF9 and infection: Pretreatment with IFN-α2B for 16 hours before HSV-1 infection significantly decreased viral replication levels relative to untreated cells 72 hours after infection in healthy control cells, but not in STAT2-, IFNAR1-, STAT1-, and IRF9-deficient cells (Supplemental Figure 3A).